Yoshihisa Tatsuoka

Kyoto, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.

Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.

Journal: The patient

Published: December 14, 2025

Epileptic seizure and migraine attack: A revisit from the "Borderland of Epilepsy" to clinical implementation of infraslow activity/DC shifts in scalp EEG

Epileptic seizure and migraine attack: A revisit from the "Borderland of Epilepsy" to clinical implementation of infraslow activity/DC shifts in scalp EEG

Journal: Rinsho shinkeigaku = Clinical neurology

Published: May 29, 2024

Novel and reappraised wide-band EEG findings in migraineurs: Its correlation with several clinical variables.

Novel and reappraised wide-band EEG findings in migraineurs: Its correlation with several clinical variables.

Journal: Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology

Published: January 26, 2024

Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial.

Efficacy of Lasmiditan Across Patient and Migraine Characteristics in Japanese Patients with Migraine: A Secondary Analysis of the MONONOFU Trial.

Journal: Advances in therapy

Published: May 27, 2022

Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies.

Early onset of efficacy with erenumab for migraine prevention in Japanese patients: Analysis of two randomized, double-blind, placebo-controlled studies.

Journal: Brain and behavior

Published: December 09, 2021

Migraine with multiple visual symptoms and out-of-body experience may mimic epilepsy

Migraine with multiple visual symptoms and out-of-body experience may mimic epilepsy

Journal: Rinsho shinkeigaku = Clinical neurology

Published: July 19, 2021

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Efficacy and safety of fremanezumab for episodic migraine prevention: Multicenter, randomized, double-blind, placebo-controlled, parallel-group trial in Japanese and Korean patients.

Journal: Headache

Published: February 10, 2021

A long-term open-label safety study of galcanezumab in Japanese patients with migraine.

A long-term open-label safety study of galcanezumab in Japanese patients with migraine.

Journal: Expert opinion on drug safety

Published: January 04, 2021

Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study.

Treatment Satisfaction of Galcanezumab in Japanese Patients with Episodic Migraine: A Phase 2 Randomized Controlled Study.

Journal: Neurology and therapy

Published: December 07, 2020

Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine.

Long-term efficacy and safety during open-label erenumab treatment in Japanese patients with episodic migraine.

Journal: Headache

Published: September 24, 2020

A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.

A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults.

Journal: Headache

Published: July 18, 2019

Changes in migraine before and after menopause in Japanese climacteric women.

Changes in migraine before and after menopause in Japanese climacteric women.

Journal: Cephalalgia : an international journal of headache

Published: June 04, 2016

Showing 1-12 of 14

Last Updated: 09/26/2026